Literature DB >> 18181525

Nanoemulsions as vehicles for transdermal delivery of aceclofenac.

Faiyaz Shakeel1, Sanjula Baboota, Alka Ahuja, Javed Ali, Mohammed Aqil, Sheikh Shafiq.   

Abstract

The aim of the present study was to investigate the potential of a nanoemulsion formulation for transdermal delivery of aceclofenac. Various oil-in-water nanoemulsions were prepared by the spontaneous emulsification method. The nanoemulsion area was identified by constructing pseudoternary phase diagrams. The prepared nanoemulsions were subjected to different thermodynamic stability tests. The nanoemulsion formulations that passed thermodynamic stability tests were characterized for viscosity, droplet size, transmission electron microscopy, and refractive index. Transdermal permeation of aceclofenac through rat abdominal skin was determined by Franz diffusion cell. The in vitro skin permeation profile of optimized formulations was compared with that of aceclofenac conventional gel and nanoemulsion gel. A significant increase in permeability parameters such as steady-state flux (J(ss)), permeability coefficient (K(p)), and enhancement ratio (E(r)) was observed in optimized nanoemulsion formulation F1, which consisted of 2% wt/wt of aceclofenac, 10% wt/wt of Labrafil, 5% wt/wt of Triacetin, 35.33% wt/wt of Tween 80, 17.66% wt/wt of Transcutol P, and 32% wt/wt of distilled water. The anti-inflammatory effects of formulation F1 showed a significant increase (P < .05) in percent inhibition value after 24 hours when compared with aceclofenac conventional gel and nanoemulsion gel on carrageenan-induced paw edema in rats. These results suggested that nanoemulsions are potential vehicles for improved transdermal delivery of aceclofenac.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18181525      PMCID: PMC2750357          DOI: 10.1208/pt0804104

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  28 in total

1.  Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac.

Authors:  Chien Ngoc Nguyen; Thi Thuy Trang Nguyen; Hanh Thuy Nguyen; Tuan Hiep Tran
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

2.  Nanoemulsion components screening and selection: a technical note.

Authors:  Adnan Azeem; Mohammad Rizwan; Farhan J Ahmad; Zeenat Iqbal; Roop K Khar; M Aqil; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

3.  Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note.

Authors:  Sheikh Shafiq; Faiyaz Shakeel; Roop K Khar
Journal:  AAPS PharmSciTech       Date:  2008-10-29       Impact factor: 3.246

4.  Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical Trial.

Authors:  B S Chandrashekhar; M Anitha; Mukesh Ruparelia; Pradyumna Vaidya; Riyaz Aamir; Sunil Shah; S Thilak; Sanjeev Aurangabadkar; Sandeep Pal; Abir Saraswat; Jayesh J Sanmukhani
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  Transdermal delivery of an anti-cancer drug via w/o emulsions based on alkyl polyglycosides and lecithin: design, characterization, and in vivo evaluation of the possible irritation potential in rats.

Authors:  Aliaa Nabil ElMeshad; Mina Ibrahim Tadros
Journal:  AAPS PharmSciTech       Date:  2010-12-09       Impact factor: 3.246

6.  Ligustrazine phosphate ethosomes for treatment of Alzheimer's disease, in vitro and in animal model studies.

Authors:  Jun Shi; Yiming Wang; Guoan Luo
Journal:  AAPS PharmSciTech       Date:  2012-03-14       Impact factor: 3.246

7.  Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

Authors:  Muthanna F Abdulkarim; Ghassan Z Abdullah; Mallikarjun Chitneni; Ibrahim M Salman; Omar Z Ameer; Mun F Yam; Elrashid S Mahdi; Munavvar A Sattar; Mahiran Basri; Azmin M Noor
Journal:  Int J Nanomedicine       Date:  2010-11-04

8.  Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery.

Authors:  Grace Ledet; Sarala Pamujula; Valencia Walker; Shana Simon; Richard Graves; Tarun K Mandal
Journal:  Drug Dev Ind Pharm       Date:  2013-04-19       Impact factor: 3.225

9.  Nanocarrier for the transdermal delivery of an antiparkinsonian drug.

Authors:  Adnan Azeem; Farhan J Ahmad; Roop K Khar; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

10.  Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial.

Authors:  Bhavik Bhavsar; Bimal Choksi; Jayesh Sanmukhani; Alka Dogra; Rizwan Haq; Sudhanshu Mehta; Santanu Mukherjee; V Subramanian; Shafiq Sheikh; Ravindra Mittal
Journal:  J Clin Diagn Res       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.